Yahoo! Sports

Study Demonstrates Early Use of Impella Can Increase Survival in Cardiogenic Shock; Escalation Protocols Initiated

Prior to the NCSI, cardiogenic shock survival rates had stagnated for the last 20 years at around 50%. The investigators of the physician-led NCSI are implementing protocols to increase survival and ...
Medscape

Impella Comes Up Short in High-Risk PCI: CHIP-BCIS3

Routine use of the Impella CP microaxial flow pump did not improve outcomes and may have contributed to deaths among patients undergoing high-risk percutaneous coronary intervention (PCI), according ...
Morningstar

Impella ECP Pivotal Study Demonstrates Safety, Efficacy for Use in High-Risk PCI

The study demonstrated Impella ECP's safety and efficacy for use in high-risk PCI. Operators chose 8Fr Angio-Seal as the first-closure method in 70% of the patients, with a 92% success rate 1.
Nasdaq

Study Finds 84% Survival Rate in Patients in Cardiogenic Shock and Other Challenging Cardiac Conditions with the New Impella 5.5 with SmartAssist

DANVERS, Mass.--(BUSINESS WIRE)-- The first published United States experience of patients who received Abiomed’s newest heart pump, Impella 5.5 with SmartAssist, finds 84% of the patients survived to ...
EurekAlert!

Impella ECP pivotal study demonstrates safety, efficacy for use in high-risk PCI

DANVERS, Mass. – October 28, 2024 – Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported with Impella ...